Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Apr 1;13(3):575-584.
doi: 10.5114/aoms.2016.60435. Epub 2016 Jun 13.

Transcatheter paravalvular leak closure and hemolysis - a prospective registry

Affiliations

Transcatheter paravalvular leak closure and hemolysis - a prospective registry

Grzegorz Smolka et al. Arch Med Sci. .

Abstract

Introduction: Paravalvular leak (PVL) related to a surgical prosthetic valve may be associated with clinically significant hemolysis. The influence of transcatheter PVL closure (TPVLC) on hemolysis remains uncertain.

Material and methods: The prospective registry included patients undergoing TPVLC due to PVL-related heart failure and/or hemolysis. Procedural data, laboratory markers of hemolysis and heart failure status were recorded at baseline, discharge and at 1- and 6-month follow-up.

Results: Of 116 patients from all those qualified for TPVLC, 79 fulfilled the inclusion/exclusion criteria. Hemolysis was significantly more frequent in patients with mitral location of PVL and with calcifications in its channel. After TPVLC prompt reduction of lactate dehydrogenase activity (617.0 (342.0-899.0) vs. 397 (310.0-480.5) IU/l, p < 0.05) and gradual resolution of anemia (hemoglobin (HGB) 11.7 (10.4-13.8) vs. 13.4 (12.9-13.8) g%, p < 0.05) over 6 months were noted. Effective closure of PVL (> 90% reduction of PVL cross-sectional area) resulted in a more prominent increase of red blood cell count and HGB than in patients with residual regurgitation. The TPVLC-related exacerbation of hemolysis was recorded in 14 patients. Its risk was aggravated by presence of significant hemolysis at baseline or residual flow either by a partially uncovered channel or across the occluder. Reduction of hemolysis after successful TPVLC was sustained in 6-month follow-up.

Conclusions: Risk factors for PVL-related hemolysis were the presence of calcifications in the defect and mitral location of PVL. The TPVLC effectively reduced hemolysis if at least 90% reduction of PVL cross sectional area was achieved. The effect was sustained in 6-month follow-up. Incomplete closure of PVL may increase the magnitude of hemolysis after TPVLC, but it occurred rarely.

Keywords: hemolysis; occluder; paravalvular leak; percutaneous closure.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
A – Multi-planar reconstruction of RT 3D TEE data set – measurement of CSA (left panel) and minimum and maximum dimensions (right panel) of mitral PVL. B – Assessment of the completeness of PVL sealing – comparison of baseline (left panel) vs. postprocedural (right panel) CSA of PVL – 75% reduction of aortic PVL CSA. C – Visualization of residual regurgitant flow through the structure of the PLD occluder (dotted black line). D – An example of a calcified PVL channel (dotted black line)
Figure 2
Figure 2
Lactate dehydrogenase activity during 6-month follow-up in all patients
Figure 3
Figure 3
Lactate dehydrogenase activity in patients with TPVLC-related hemolysis
Figure 4
Figure 4
Changes of LDH activity in pairs of samples

References

    1. Horstkotte D, Korfer R, Seipel L, Bircks W, Loogen F. Late complications in patients with Bjork-Shiley and St. Jude Medical heart valve replacement. Circulation. 1983;68:II175–84. - PubMed
    1. O’Rourke DJ, Palac RT, Malenka DJ, Marrin CA, Arbuckle BE, Plehn JF. Outcome of mild periprosthetic regurgitation detected by intraoperative transesophageal echocardiography. J Am Coll Cardiol. 2001;38:163–6. - PubMed
    1. Rallidis LS, Moyssakis IE, Ikonomidis I, Nihoyannopoulos P. Natural history of early aortic paraprosthetic regurgitation: a five-year follow-up. Am Heart J. 1999;138:351–7. - PubMed
    1. Davila-Roman VG, Waggoner AD, Kennard ED, et al. Prevalence and severity of paravalvular regurgitation in the Artificial Valve Endocarditis Reduction Trial (AVERT) echocardiography study. J Am Coll Cardiol. 2004;44:1467–72. - PubMed
    1. de Almeida Brandao CM, Pomerantzeff PM, Souza LR, et al. Multivariate analysis of risk factors for hospital mortality in valvular reoperations for prosthetic valve dysfunction. Eur J Cardiothorac Surg. 2002;22:922–6. - PubMed

LinkOut - more resources